Daniel W Carr

12PUBLICATIONS
10CO-AUTHORS
Haematological tumoursInnate immunityDisease surveillanceAgricultural molecular engineering of nucleic acids and proteinsGenetically modified animals
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jan 22, 2024
Complement Suppresses the Initial Type 1 Interferon Response to Ocular Herpes Simplex Virus Type 1 Infection in Mice.

Daniel J J Carr, Adrian Filiberti, Grzegorz B Gmyrek

|Sep 23, 2022
HSV-1 0∆NLS vaccine elicits a robust B lymphocyte response and preserves vision without HSV-1 glycoprotein M or thymidine kinase recognition.

Grzegorz B Gmyrek, Amanda N Berube, Virginie H Sjoelund

|Mar 26, 2022
Tripartite-Motif 21 (TRIM21) Deficiency Results in a Modest Loss of Herpes Simplex Virus (HSV)-1 Surveillance in the Trigeminal Ganglia Following Cornea Infection.

Amanda Berube, Grzegorz B Gmyrek, Derek J Royer

|Jan 19, 2022
Noncognate Signals Drive Enhanced Effector CD8+ T Cell Responses through an IFNAR1-Dependent Pathway after Infection with the Prototypic Vaccine, 0ΔNLS, against Herpes Simplex Virus 1.

Grzegorz B Gmyrek, Paul Predki, Edward Gershburg

|Nov 27, 2021
The Durability of Vaccine Efficacy against Ocular HSV-1 Infection Using ICP0 Mutants 0∆NLS and 0∆RING Is Lost over Time.

Daniel J J Carr, Amanda Berube, Edward Gershburg

|Apr 03, 2021
Assessment of Two Novel Live-Attenuated Vaccine Candidates for Herpes Simplex Virus 2 (HSV-2) in Guinea Pigs.

Jonathan D Joyce, Anant K Patel, Brandie Murphy

Pageof 2

Frequent Collaborators

1 joint publications

Derek J Royer

1 joint publications

Adrian Filiberti

1 joint publications

Virginie H Sjoelund

1 joint publications

Andrea S Bertke